Page 5,099«..1020..5,0985,0995,1005,101..5,1105,120..»

Women reconsidering hormone replacement therapy

Posted: Published on June 28th, 2013

MIAMI - Although many women are frightened by concerns of a potential link between hormone replacement therapy and cancer or heart disease, some are re-evaluating that risk in the light of new conclusions. Maria Venereo said she was hesitant to undergo hormone replacement therapy at first. "I heard a lot of stories and reading about it and all that, I said, yeah, I'll put it off, I'll put it off," she said. "[I] try a few things, natural stuff, didn't work." Venereo turned to Cooper City midwife Karen Bosia for guidance and found reassurance. "I personally take estrogen every day, and I've been taking it for 12 years and I don't plan on stopping it," said Bosia. Bosia said the conventional belief that hormone replacement therapy is dangerous is based on research done over a decade ago using synthetic hormones. "The synthetics are, you know, chemically produced and they're not exactly the same as what your body produces," she added. Bosia and many other doctors now use individually compounded bio-identical hormones. "A bio-identical is taken from the yam plant and it's structured -- if you look at the hydrogens and the oxygens -- it's structured exactly like the estradiol and … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Women reconsidering hormone replacement therapy

Final speech Stem cell Research – Video

Posted: Published on June 28th, 2013

Final speech Stem cell Research By: Kelsey Schimmel … Continue reading →

Posted in Stem Cell Research | Comments Off on Final speech Stem cell Research – Video

Channel Ten Stem Cell Research Story – Video

Posted: Published on June 28th, 2013

Channel Ten Stem Cell Research Story Channel Ten stem cell research story, featuring Spinal Cord Injuries Australia and Walk On client Rod Watson. By: SpinalCordInjuriesAu … Continue reading →

Posted in Stem Cell Research | Comments Off on Channel Ten Stem Cell Research Story – Video

King’s College London: The future of stem cell research – Video

Posted: Published on June 28th, 2013

King's College London: The future of stem cell research In recent years there has been an explosion of interest in stem cells within the scientific and medical communities, as well as amongst politicians, pharmace... By: kingscollegelondon … Continue reading →

Posted in Stem Cell Research | Comments Off on King’s College London: The future of stem cell research – Video

Pluripotent stem cell-derived neurons may be a viable Parkinson’s disease treatment

Posted: Published on June 28th, 2013

Public release date: 28-Jun-2013 [ | E-mail | Share ] Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair Putnam Valley, NY. (Jun. 28 2013) A team of researchers from Rush University, Yale University, the University of Colorado and the St. Kitts Biomedical Research Foundation transplanted human embryonic stem cells into primate laboratory animals modeled with Parkinson's disease and found "robust survival" of the cells after six weeks and indications that the cells were "well integrated" into the host animals. The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct1000wakeman. "Parkinson's disease was one of the first neurological disorders to be studied for potential replacement of lost neurons," said Dr. D. Eugene Redmond of Yale University School of Medicine. "Since the 1970s there has been significant progress with learning the required gene expression, growth factors and culture conditions for differentiating cells into apparent dopamine neurons." However, the researchers noted that transplanted dopamine neurons have not produced "long-lasting midbrain specific neurons when transplanted into rodents or monkeys" and there have only been pilot reports of functional improvement. According to the study authors, their study tested the … Continue reading →

Posted in Stem Cell Research | Comments Off on Pluripotent stem cell-derived neurons may be a viable Parkinson’s disease treatment

ReproCell Set to Quadruple From IPO on Stem-Cell Optimis

Posted: Published on June 28th, 2013

ReproCell Inc. (4978), a stem-cell medical research company, is heading for the biggest opening jump for a Japanese initial public offering in nine years. Shares of the biotech company were untraded a second day after debuting on Osakas JASDAQ exchange yesterday. The stock was bid at 14,180 as of 1:09 p.m. in Tokyo and is poised to open trading 343 percent higher than its IPO price of 3,200 yen. Buy orders outnumbered sell orders by about 4-to-1. Founded in 2003, ReproCell was the first company licensed to generate induced pluripotent stem cells, or iPS cells, according to the company website. Kyoto University professor Shinya Yamanaka won a Nobel Prize for medicine in October after discovering a new way to transform ordinary skin cells into iPS cells. Riken, a state scientific research institute, said the cells have potential for treating cancer. Investors are focusing on the dream, said Toshiaki Iwasaki, an analyst at Mito Securities Co. Ltd. They are buying because of optimism about iPS. Investors are also hopeful that ReproCells technology will be used by cosmetic companies as well as pharmaceutical firms. If the shares open at the current price, this will be the largest surge on a Japanese trading … Continue reading →

Posted in Stem Cell Research | Comments Off on ReproCell Set to Quadruple From IPO on Stem-Cell Optimis

International Stem Cell Corporation to Present Data From Its Parkinson’s Disease Program at Society for Neuroscience …

Posted: Published on June 28th, 2013

CARLSBAD, CA--(Marketwired - Jun 27, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies, announced today that it will present preliminary data from its IND-enabling study in Parkinson's disease at the Society for Neuroscience annual meeting in San Diego, CA on November 10th 2013. The Society for Neuroscience is the world's largest organization of scientists and clinicians devoted to understanding the brain and nervous system. More than 30,000 people are expected to attend the annual meeting, making it one of the largest scientific and medical conferences in the world. ISCO's Parkinson's disease program uses human parthenogenetic neural stem cells (hPNSC) which are a novel therapeutic cellular product derived from the company's proprietary histocompatible human pluripotent stem cells. hPNSC are self-renewing mulitpotent cells that are precursors for the major cells of the central nervous system. The ability of hPNSC to (i) differentiate into dopaminergic (DA) neurons and (ii) express neurotrophic factors such as glial derived neurotrophic factor (GDNF) and brain derived neurotrophic factor (BDNF) to protect the nigrostriatal system, offers a new opportunity for the treatment of Parkinson's disease, especially in cases where current small molecule approaches fail to adequately control … Continue reading →

Posted in Stem Cell Research | Comments Off on International Stem Cell Corporation to Present Data From Its Parkinson’s Disease Program at Society for Neuroscience …

Higher genetic risk tied to lifetime asthma suffering

Posted: Published on June 28th, 2013

Public release date: 27-Jun-2013 [ | E-mail | Share ] Contact: Kendall Morgan Kendall.morgan@duke.edu 919-684-2850 Duke University DURHAM, N.C. -- Children with more genetic risks for asthma are not only more likely to develop the condition at a young age, but they are also more likely to continue to suffer with asthma into adulthood. The finding reported by Duke University researchers is one of the latest to come from a 40-year longitudinal study of New Zealanders. "We've been able to look at how newly discovered genetic risks relate to the life course of asthma at an unprecedented level of resolution," said Daniel Belsky, a postdoctoral fellow at the Duke Institute for Genome Sciences & Policy and the Center for the Study of Aging and Human Development. Earlier studies had linked several genes to small increases in asthma risk. Belsky, along with Duke's Avshalom Caspi, Terrie Moffit and others, wanted to know whether those individual risks literally add up. They looked to the Dunedin Multidisciplinary Health and Development Study, an effort to examine the behavior and health -- including lung function -- of 1,037 individuals who have been tracked since their birth in Dunedin, New Zealand during a 12-month period from … Continue reading →

Comments Off on Higher genetic risk tied to lifetime asthma suffering

Genetic Test Could Predict Which Kids Will Have Lasting Asthma Symptoms

Posted: Published on June 28th, 2013

dagmar heymans / Getty Images Half of children with asthma will continue to suffer from the respiratory disorder as adults, and a new genetic test could reveal who remains at risk past childhood. About one in 11 children suffers from asthma, according to the Centers for Disease Control (CDC), and although half will eventually grow out of the condition, a recent CDC survey found that medical costs of asthma and its complications add up to about $56 billion each year. Improved treatment of those most likely to live with their condition longer term, say experts, could help to lower some of these costs, which include treating complications and mismanaged symptoms. Researchers report in the journal Lancet Respiratory Medicine that a new genetic test may be able to predict a childs risk of having asthma into adulthood, and therefore help doctors figure out which children might need more intensive care in childhood to potentially lower their risk of longer term symptoms. (MORE: Experimental Asthma Drug May Provide Major ReliefBut For a Limited Group of Patients) The new study piggy backs on so-called genome-wide association (GWAS) studies, which compare those affected by asthma to those who are not to isolate specific genetic … Continue reading →

Comments Off on Genetic Test Could Predict Which Kids Will Have Lasting Asthma Symptoms

Study Shows Genetic Testing Promise for Predicting Asthma

Posted: Published on June 28th, 2013

Study reveals genetic testings promise for predicting which children will grow out of asthma Genetic risk assessments could be used to predict which children with asthma are likely to grow out of the condition, and which will continue having symptoms as they grow older, new research emerging from the University of Otagos world-renowned Dunedin Multidisciplinary Study suggests. A team of Otago and Duke University researchers set out to test how genetic discoveries about asthma predisposition relate to the developmental and biological characteristics of the condition. Their findings are newly published Online First in the UK journal The Lancet Respiratory Medicine. After analysing data from the long-running Dunedin Multidisciplinary Health and Development Study of around 1,000 children born in 1972-73, the team discovered that those with childhood asthma and higher genetic risk scores for being predisposed to it were more than one-third (36%) more likely to develop asthma that persists throughout their lives than those found to have a lower genetic risk. Approximately half of all children with asthma will grow out of it by the time they reach adolescence or adulthood. Currently, there are no tests that can predict which children will never grow out of asthma and which will … Continue reading →

Comments Off on Study Shows Genetic Testing Promise for Predicting Asthma

Page 5,099«..1020..5,0985,0995,1005,101..5,1105,120..»